Mersana Therapeutics buy BTIG Research
Start price
29.02.24
/
50%
€5.00
Target price
28.02.25
€5.54
Performance (%)
-45.32%
Price
26.04.24
€2.73
Summary
This prediction is currently active. Massive losses of -45.32% have been the result for the BUY prediction by BTIG_Research. This prediction currently runs until 28.02.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | -10.507% | -10.507% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by BTIG_Research for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat